Overview
Research investment company owned by Parkinson's UK, partnering with companies, institutions and co-investors to develop disease-modifying and symptomatic treatments for Parkinson's disease.
Unlock the full profileGet the complete company dossier
This public view only shows an extract. Open the full profile to access the complete company intelligence record, including the full write-up and structured research details.